These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing, reported early 2004-004004-20 A Randomised, Double-blind, Placebo Controlled trial to test the efficacy of St John's Wort (Hypericum Perforatum) for Premenstrual Syndrome. not-yet-due
Ongoing, reported early 2004-005188-12 DENTAL TRAUMA: The effectiveness of an internet based computer database for data collection in a randomised controlled trail to evaluate immediate extirpation of necrotic pulp tissue and placement of ... not-yet-due
Ongoing 2005-000674-43 AN OPEN LABEL STUDY OF THE EFFECT OF TREATMENT WITH RITUXIMAB ON RESISTANT RHEUMATOID ARTHRITIS: not-yet-due
Ongoing 2005-000686-19 PACT (Patient Preferences in Adjuvant Colorectal Cancer Therapy) - A randomised crossover clinical trial comparing Bolus Fluorouracil/Leucovorin to Capecitabine as treatment for moderate to high risk ... not-yet-due
Ongoing 2005-001195-13 The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) Prisons Project: An open label pragmatic randomised control trial comparing the efficacy of differing therapeutic agents for prison pri... not-yet-due
Reported results 2005-003492-20 A randomised clinical trial of treatment for fluorouracil-resistant advanced colorectal cancer comparing standard single-agent irinotecan versus irinotecan plus panitumumab and versus irinotecan plus ... 2014-03-17 due-trials
Ongoing 2005-004582-41 Safety and efficacy of combination treatment with rituximab and leflunomide in patients with active rheumatoid arthritis not-yet-due
Ongoing, reported early 2005-005013-37 A multi-centre randomised double dummy double blind study comparing two regimens of combination induction therapy in early DMARD naive Rheumatoid Arthritis: The IDEA study (Infliximab as Induction The... not-yet-due
Ongoing, reported early 2005-005467-29 A multi-centre randomised trial of Etanercept and Methotrexate to induce remission in early inflammatory arthritis resistent to corticosteroid challenge: The EMPIRE trial not-yet-due
Not reported 2006-003932-32 Endocrine +/- Surgical Therapy for Elderly women with Mammary cancer 2009-11-05 due-trials
Ongoing, reported early 2006-005640-81 A PLACEBO CONTROLLED STUDY OF THE EFFECT OF EXTENDED TREATMENT WITH RITUXIMAB ON RESISTANT RHEUMATOID ARTHRITIS: not-yet-due
Ongoing, reported early 2007-004757-28 A randomised controlled single-blind trial to compare intensive management vs standard care in early psoriatic arthritis not-yet-due
Reported results 2007-006234-34 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: endothelial and endothelial progenitor cell function in men 2011-07-19 due-trials
Not reported 2008-002335-32 Does concentration affect the ED50 of bupivacaine for supraclavicular brachial plxus block? 2009-07-08 due-trials
Ongoing, reported early 2008-003011-12 Prospective Randomised Double-Blind Placebo Controlled Study Assessing the Efficacy of Tocilizumab with Synovial Analysis in Patients with Rheumatoid Arthritis not-yet-due
Ongoing 2008-004877-17 Prospective, Single-centre, Double-Blind, Randomised, Placebo-controlled Study Evaluating Efficacy of Adalimumab + Methotrextate Compared with Placebo + Methotrexate in Patients with Early Oligoarthri... not-yet-due
Not reported 2008-004878-41 ASUS: Abatacept in Seronegative Undifferentiated arthritis Study Prospective, Single-centre, Pilot Study Assessing the Efficacy of Abatacept in Anti-CCP Negative Undifferentiated Inflammatory Arthriti... 2013-07-11 due-trials
Ongoing, reported early 2008-007875-26 Modulation of Clot Structure and Platelet Function by Aspirin in Individuals with Diabetes: the role of aspirin dose and Glycaemic control not-yet-due
Ongoing, reported early 2008-008177-57 “What is the ED95 dose of Prilocaine for femoral nerve block using ultrasound?” not-yet-due
Reported results 2008-008237-11 An open label study to assess the effectiveness of oral methotrexate in reducing pain in knee osteoarthritis 2011-02-09 due-trials
Ongoing 2009-010956-93 Randomised comparisons, in myeloma patients of all ages, of thalidomide, lenalidomide, carfilzomib and bortezomib induction combinations, and of lenalidomide and combination lenalidomide vorinostat as... not-yet-due
Reported results 2009-011173-32 Treating painful hand osteoarthritis using low dose oral prednisolone- assessing short-term pain and imaging outcomes 2010-11-23 due-trials
Reported results 2009-011829-13 What is the ED95 dose for bupivacaine for supraclavicular brachial plexus block using ultrasound? 2011-03-14 due-trials
Ongoing 2009-011907-22 Antiplatelet treatment in patients with diabetes mellitus: is there a difference between aspirin, clopidogrel and prasugrel not-yet-due
Ongoing 2009-015058-38 Improving the outcome for patients after osteoporotic femoral fractures not-yet-due
Reported results 2009-015810-23 Intra-articular and intravenous infliximab in the treatment of resistant seronegative oligoarthritis of the knee 2011-06-30 due-trials
Ongoing, reported early 2009-015903-22 THE EFFECT OF EICOSAPENTAENOIC ACID (EPA) ON BIOMARKERS OF GROWTH AND VASCULARITY IN HUMAN COLORECTAL CANCER LIVER METASTASES not-yet-due
Not reported 2009-016855-23 Targeting systemic inflammation to improve endothelial function in obesity 2013-08-05 due-trials
Reported results 2009-017925-20 Does Cocareldopa treatment in combination with routine NHS occupational and physical therapy, delivered early after stroke within a stroke service, improve functional recovery including walking and ar... 2015-03-27 due-trials
Ongoing 2010-018466-22 ED95 doses of commonly used local anaesthetic agents for ultrasound guided brachial plexus blocks not-yet-due
Ongoing 2010-020943-10 A randomised controlled trial of eicosapentaenoic acid (EPA) and/or aspirin for colorectal adenoma (or polyp) prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme: T... not-yet-due
Reported results 2010-021430-64 A randomised double blind placebo controlled clinical trial of anti B-cell therapy in patients with primary Sjögren’s syndrome. 2015-01-16 due-trials
Ongoing, reported early 2010-021451-12 An open label, multi-centre, randomised, parallel group phase II selection trial to identify the optimal starting dose of bendamustine (60 vs 100 mg/m2) when given in combination with thalidomide and ... not-yet-due
Ongoing, reported early 2010-023880-17 SWITCH: Randomised-controlled trial of switching to alternative tumour-necrosis factor (TNF)-blocking drugs or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial T... not-yet-due
Ongoing 2010-023910-30 A Prospective, Single-centre, Randomised Study Evaluating the Clinical, Imaging and Immunological Depth of Remission Achieved by Very Early versus Delayed Etanercept in patients with Rheumatoid Arthri... not-yet-due
Ongoing 2011-001098-16 STAR: A Randomised Multi-Stage Phase II/III trial of Sunitinib comparing Temporary cessation with Allowing continuation, at the time of maximal radiological response, in the first-line treatment of lo... not-yet-due
Ongoing 2011-001914-33 A phase 1/2a, dose escalation study of CHR-3996 in combination with tosedostat in subjects with relapsed, refractory multiple myeloma not-yet-due
Ongoing 2011-004017-17 Prospective, Single-centre, Open-Label, Randomised, Pilot Study Assessing the changes in expression of JAK-STAT and Speed & Depth of Remission Induced by Tocilizumab & Methotrexate Combination and Toc... not-yet-due
Ongoing 2011-004072-10 FGFR Inhibition for Epithelial Solid Tumours: a Phase Ib trial of AZD4547 in combination with gemcitabine and cisplatin not-yet-due
Ongoing 2011-004300-38 HERO:Hydroxychloroquine Effectiveness in Reducing Symptoms of hand OA, a randomised, double-blind, placebo-controlled trial not-yet-due
Ongoing 2011-005361-20 A Phase II Trial of combination treatment with Vorinostat, Bortezomib and Dexamethasone in participants with Relapsed Multiple Myeloma not-yet-due
Ongoing, reported early 2012-000842-36 A Phase I/IIa trial of VTD-panobinostat treatment and panobinostat maintenance in relapsed and relapsed/refractory multiple myeloma patients not-yet-due
Ongoing 2012-001320-36 A phase II randomised trial of carfilzomib, cyclophosphamide and dexamethasone (CCD) vs cyclophosphamide, velcade and dexamethasone (CVD) for first relapse or primary refractory multiple myeloma. not-yet-due
Listed as ongoing, but also has a completion date 2012-002623-15 GLiSten: Next generation intraoperative lymph node staging for stratified colon cancer surgery- Development Phase 2015-08-07 bad-data
Ongoing 2012-002640-25 A prospective, single-centre, feasibility study evaluating the prevalence of diagnostic clinical imaging features of subclinical enthesitis in patients with moderate to severe plaque psoriasis and the... not-yet-due
Not reported 2012-003736-23 RETREAT(F) (REmoval of Treatment for patients in REmission in psoriatic ArThritis – Feasibility study). A randomised controlled trial to compare withdrawal of therapy versus continuing therapy in low ... 2013-12-02 due-trials
Ongoing 2012-004537-16 An Open Label Multi-Centre Preoperative Window of Opportunity Study of Afatinib in Stage Ia to IIb Non-Small Cell Lung Cancer not-yet-due
Ongoing 2013-000867-10 Effects of Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction (HF-PEF): Cardiac MRI, Echocardiography, Exercise Physiology & Quality of Life Assessment not-yet-due
Ongoing 2013-001689-41 Pain Reduction with Oral Methotrexate in knee Osteoarthritis, a pragmatic phase III trial of Treatment Effectiveness not-yet-due
Ongoing 2013-001944-76 FLAIR: Front-Line therapy in CLL: Assessment of Ibrutinib + Rituximab not-yet-due
Not reported 2013-002101-62 Pomalidomide in relapsed and refractory multiple myeloma (RRMM) 2015-10-13 due-trials
Ongoing 2013-002777-22 Targeted Ultrasound in Rheumatoid Arthritis (TURA) not-yet-due
Ongoing 2014-000880-42 GALACTIC: GA-101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL not-yet-due
Ongoing 2014-004511-36 A randomised phase II trial of Cyclophosphamide and Dexamethasone in combination with Ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalid... not-yet-due
Ongoing 2014-004741-27 Comparison of Alitretinoin with PUVA as the first line treatment in patients with severe chronic hand eczema not-yet-due
Ongoing 2015-001602-33 A single arm, phase II open label trial to investigate the efficacy and safety of intra-dermal injection of etanercept for remission induction in discoid lupus erythematosus not-yet-due
Ongoing 2016-000628-24 A randomised placebo-controlled phase III trial of the effect of the omega-3 fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver meta... not-yet-due
Ongoing 2016-002670-12 MUK nine b: OPTIMUM. A phase II study evaluating multiple novel agentsoptimised combination of biological therapy in newly diagnosed high risk multiple myeloma and plasma cell leukaemia. not-yet-due
Ongoing 2016-003128-22 Intraoperative imaging of colon cancer using a fluorescent peptide (EMI-137) against the c-Met receptor not-yet-due
Ongoing 2017-001476-33 A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma not-yet-due
Ongoing 2017-003593-13 UK CLL Long-term Follow-up Study not-yet-due